Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
about
Depression and postoperative complications: an overviewPatients with preexisting psychiatric disorders admitted to ICU: a descriptive and retrospective cohort studyThe puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Depression, medication adherence, and service utilization in systemic lupus erythematosusPerceptions of cardiac risk among a low-income urban diabetic population.Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital dischargeDesign and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trialPersistent comorbid symptoms of depression and anxiety predict mortality in heart disease.Depressive symptoms and cardiovascular health by the American Heart Association's definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyAre AMI patients with comorbid mental illness more likely to be admitted to hospitals with lower quality of AMI care?Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromesThe Effect of Self-Care Education on the Awareness, Attitude, and Adherence to Self-Care Behaviors in Hospitalized Patients Due to Heart Failure with and without DepressionPosttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacksAnxiety, depression, and quality of life in primary care patients.Depression and coronary heart diseaseAntidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain.The effect of enhanced depression care on adherence to risk-reducing behaviors after acute coronary syndromes: findings from the COPES trial.Predictors of medication adherence in elderly patients with chronic diseases using support vector machine modelsStress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.Depression treatment in patients with coronary artery disease: a systematic review.Broken-hearted women: the complex relationship between depression and cardiovascular disease.Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team.Antiplatelet therapy: aspirin resistance and all that jazz!Effects of depressive and other psychiatric disorders on anticoagulation control in a pharmacist-managed anticoagulation clinic.Aspirin for cardioprotection and strategies to improve patient adherence.Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review.Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology.Psychological Aspects of Cardiac Care and Rehabilitation: Time to Wake Up to Sleep?Cardiac Rehabilitation in Patients with Established Atherosclerotic Vascular Disease: New Directions in the Era of Value-Based Healthcare.Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology.Role of depressive symptoms and self-efficacy of medication adherence in Korean patients after successful percutaneous coronary intervention.Relations among depressive symptoms, electrocardiographic hypertrophy, and cardiac events in non-ST elevation acute coronary syndrome patients.Aspirin adherence, depression and one-year prognosis after acute coronary syndrome.Factors associated with persistent risk of depression in older people following discharge from an acute cardiac unit.Plasma sphingolipids and depressive symptoms in coronary artery disease.Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study.The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severity.Depressive symptoms moderate the relationship between medication regimen complexity and objectively measured medication adherence in adults with heart failure.
P2860
Q26772908-A44E4BBE-1A47-46F1-9EEB-9DA0586D2B0BQ29247964-F45DD472-3FD3-4194-BBF5-B0AEE547AB96Q33351796-63C483E1-B825-47ED-9E4C-1AF27AA1D754Q33871960-7EE587F8-56AF-4521-B2B9-85CF3871148EQ33873515-729CF5FF-FFB8-4CAF-AD7F-91F7BE024BE8Q34011825-2184E395-5B21-47EE-B395-F7753B26F449Q34274017-F1241F60-567B-4C8D-9A35-5ECB985B334CQ34284707-CB048090-2424-4E72-8FC6-0E6DDB0C1F9BQ34388376-FD999C7A-8A2C-4BE2-A5CD-CDCB029F55ABQ34541151-3A2E21B2-4110-4D16-B47A-69A6747B226AQ34658265-F9F99D86-87EB-4EDA-8037-11E49D77BE61Q35032401-9E34E5B3-E3E6-4744-A330-EF39442B3C88Q35668725-91CB1C0D-F4CC-4EB5-944F-E76B658ECE51Q36113388-A6159231-E56B-4708-AADE-19E4AC35C1FDQ36274277-8AA01870-920C-4CDD-A382-EAD9A372025AQ36446704-6093CC68-8BB3-4AF2-8692-BB8E22BD3591Q36674169-7396146E-3C28-4A7A-9A52-98D2D2137357Q36714056-7F13674D-84F2-487B-98D3-D92139A49B23Q36786586-58D494CC-1019-4A71-BF30-65E425E8FD40Q37035595-6A3060C6-376E-4C73-AAE6-B20354E686ABQ37116113-44BC4966-47A7-4690-911A-F08256B8A5B7Q37533862-AE050EB5-8DA6-43B6-BA67-A0909308E68BQ37622990-26440B38-1D98-4772-8DFC-A5F571B04F8BQ37712347-024BD1C4-7C2E-4AB1-9307-ECDBAE7837E0Q38023196-BDEEB5D1-BFC9-41BD-8F41-BD49FB089473Q38164681-87F171BA-B43A-4597-900A-D69E806BB9D7Q38176141-BD8C3C55-A04E-4E29-9546-D66512F2645FQ38219811-19DEB114-EB17-4ADB-8DB5-F84746D4702FQ38233653-387F9646-CD8A-45A5-BA65-3B7FF6BB2C29Q38611528-A08C62EE-41EC-4919-8A97-F70128FC0F13Q38709290-93AE3D98-CC77-492E-9D1A-C62B899D8EF1Q38769495-6C64F851-8104-4E84-B424-DCD0C5E1C50EQ39334425-217BE90F-CA68-4FF1-BCFE-3CE28936FC94Q39999501-1F22E237-7E9A-4716-8BA4-4F7B4A3578A0Q42789086-81990CC1-9C06-4267-9B8E-A48082ACCFBAQ44397352-E43F8058-60FE-4133-A9E6-ED36B0359B00Q46248790-40416088-463D-4753-96D1-CDAE683A867EQ47563434-AAAD394E-9304-4974-A062-148CBCBB7D30Q47882749-45F33A9D-5CCB-434A-A355-5282114D6BBAQ47971201-611A0914-6A85-4822-9B0D-B5926CFEE0F4
P2860
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@ast
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@en
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@nl
type
label
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@ast
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@en
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@nl
prefLabel
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@ast
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@en
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@nl
P2093
P50
P1476
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
@en
P2093
David Vorchheimer
Donald Haas
Matthew M Burg
William F Chaplin
William Gerin
P356
10.1016/J.AHJ.2006.05.014
P407
P577
2006-11-01T00:00:00Z